Browse by ▼

Walgreen Company

  • Want Shares of a Legal Drug Dealer?

    By Chris Hodge - May 23, 2013 | Tickers: CVS, GNC, WAG

    I've been on a drug manufacturer kick lately, but got to thinking about how many disadvantages they have. While the manufacturer gets the most profit out of a successful drug, they also feel the pain when a lot of their potential drugs never get through clinical trials and have to be dropped. But what about the companies that can sell successful prescriptions or supplements, as well as more commonplace more »

  • More Upside Still for Rite Aid?

    By Nick Chiu - May 22, 2013 | Tickers: CVS, RAD, WAG

    Rite Aid (NYSE: RAD) is one of the nation’s largest drugstore chains, operating drugstores in 31 states across the U.S. and in the District of Columbia. Rite Aid continues to rally despite the declining same store sales for April. Rite Aid’s share price had more than doubled since the beginning of the year, outperforming Walgreen (NYSE: WAG) and CVS Caremark (NYSE: CVS). Walgreen had advanced 34.78 more »

  • This Company Is Making a Killing on the Patent Cliff

    By Mohammed Shaaban - May 22, 2013 | Tickers: CVS, RAD, WAG | Editor's Choice

    If you have been following the pharmaceutical industry lately, then you're probably no stranger to the "Patent Cliff" phenomenon that the industry is facing. The giant pharmaceutical companies are struggling to get new medications approved to replace the onslaught of blockbuster drugs that were approved in the 1990s, and are currently going off patent year after year.

    This following is a chart depicting the number of new medications approved more »

  • OTCs and then Some

    By Kyle Vaughan - May 21, 2013 | Tickers: CVS, ESRX, WAG

    My grandfather still uses the word "drugstore" to describe a general retail establishment where one can purchase medication, food and beverage items, and a variety of other household consumer goods. His perception of this type of store came long before the nationwide rise of Wal-Mart, Target, and dollar stores that now dominate retail. Although barriers to entry may appear to be tall, Walgreen (NYSE: WAG) is showing no signs of more »

  • Will Rite Aid’s Rally Continue?

    By Lior Cohen - May 20, 2013 | Tickers: CVS, RAD, WAG

    The health store sector isn’t showing signs of recovery; revenues of leading drugstore chains remained stable as in the case of Walgreen (NYSE: WAG) or slightly declined as in the case of Rite Aid (NYSE: RAD). And yet these companies’ stocks continue to trade up. The company that led the charge in the stock market in recent months was Rite Aid as its stock spiked by more than 91 more »

  • The Pharmacy America Trusts Fights Back

    By Nauman Aly - May 20, 2013 | Tickers: CVS, ESRX, WAG

    Walgreen (NYSE: WAG) recently made mistakes that temporarily affected its stock in a negative way. Its greatest error was choosing to not participate in the Express Scripts (NASDAQ: ESRX) program, which is a very popular program among Walgreen customers. This move caused Walgreen to lose millions of customers to competitors, such as CVS Caremark (NYSE: CVS), and other pharmacies like Wal-Mart.

    Luckily for investors, Walgreen decided to reverse this decision more »

  • 3 Must-Own Stocks from Barron's Insider Buying List

    By John Macris - May 13, 2013 | Tickers: BAC, HBAN, WAG

    One of my weekly rituals as an investor is to review recent insider activity through the Securities and Exchange Commission’s Form 4 filings. Corporate executives and board members (“insiders”) are required to fully disclose their stock purchases pursuant to the Securities Exchange Act of 1934 and the Investment Company Act of 1940.

    Barron's magazine makes an effort to highlight the most noteworthy insider purchases and organizes them in more »

  • Retail Pharmacies Have the Profit Remedy

    By Kyle Colona - May 10, 2013 | Tickers: CVS, ESRX, WAG

    The retail pharmacy sector had an excellent first quarter across the board. These outfits offer investors a safe harbor in the choppy water of the overdue economic recovery. This article will focus on the three key players: Walgreen (NYSE: WAG), Express Scripts (NASDAQ: ESRX) and my personal choice, CVS Caremark (NYSE: CVS). All three reported strong sales, and the share price of each saw solid gains in the first quarter more »

  • Is CVS Caremark Still a Buy?

    By Shmulik Karpf - May 8, 2013 | Tickers: CVS, XLV, WMT, WAG

    Shares of CVS Caremark (NYSE: CVS) have enjoyed a fantastic run over the past six months. From a price of $44 only six months ago, shares advanced to a roughly $60 price tag today - an impressive 36% rise in such a short time. Not only that, but CVS also vastly outperformed the health care sector as a whole. Take a look at the graph below.

    From looking at the graph more »

  • Playing the Pharmaceutical Distribution Stocks

    By Anh HOANG - May 7, 2013 | Tickers: ABC, ESRX, WAG

    According to Barron’s, Maxim Group ranked Express Scripts Holding Company (NASDAQ: ESRX) as a buy after its better-than-estimated first quarter earnings results. Since the beginning of the year, Express Scripts has experienced a gain of 10.4%, lower than the S&P 500’s gain of nearly 11%. However, in a longer historical time horizon of 5 years, the company has gained more than 67.5%, leaving the S more »

  • Drugstore Wars: Walgreen or CVS Caremark?

    By Joseph Harry - May 7, 2013 | Tickers: ABC, CVS, WAG

    Drugstores should make viable investments going forward as a way to play the demand for drugs that will inevitably increase with an aging population that's led by the baby boomers. The Affordable Care Act, or "Obamacare," should also fuel demand for cheaper generics, as well as generate more foot traffic in stores such as Walgreen (NYSE: WAG) and CVS Caremark (NYSE: CVS)). So which drugstore makes a better investment more »

  • The Generic Shift Leaves Pharmacy Investors Well Positioned

    By Brian Nichols - May 6, 2013 | Tickers: CVS, RAD, WAG

    All three of the major pharmacy companies, Rite Aid (NYSE: RAD), CVS Caremark (NYSE: CVS), and Walgreen (NYSE: WAG), operate with similar business models, having both retail and pharmacy segments. Yet for all of these three companies, the pharmacy business is the most watched and produces the greatest difference in sales and margins. With that said, anyone following the space must be glad with what they are seeing develop.

    A more »

  • Settlement Turns Walgreens Into A Monster

    By Dana Blankenhorn - May 2, 2013 | Tickers: CVS, ESRX, WAG

    Since settling its dispute with ExpressScripts (NASDAQ: ESRX) Walgreen (NYSE: WAG) has been on fire, with the stock rising 61% against a 20% gain for rival CVS Caremark (NYSE: CVS).

    What's going on? And can Walgreen keep it up?

    The PBM Dispute

    ExpressScripts is a Pharmacy Benefit Manager, or PBM, and the country's largest. It acts as a gatekeeper between the insurance industry and drug benefits. If you more »

  • Dividend Aristocrats That Sweep You Off Your Feet

    By AnnaLisa Kraft - May 1, 2013 | Tickers: ADM, BDX, DOV, CB, WAG

    In an effort to educate the 34% of women who know nothing of investing, Yahoo! Finance has a saucy video for the ladies featuring three barechested studs representing stocks, bonds, and mutual funds. Why Mr. Stocks is the skinniest, I'm sure I don't know, because how much more appealing would Mr. Stocks be if they mentioned how he bulks up when you add dividends?

    Maybe they should have more »

  • Will This "Perfect" Drug Retail Stock Continue to Dominate?

    By Nauman Aly - April 29, 2013 | Tickers: CVS, RAD, WAG

    In many cities across the U.S., you would be hard pressed not to find a CVS Caremark (NYSE: CVS) location on just about every street corner. Some analysts have stated that as this company continues to grow, it has shown signs of being "the perfect stock" - inclusive of both excellent returns and sizable gains. But how long will CVS continue on its steady uptrend?

    Finding a cure for growing more »

  • Checking in on This Ex-Lehman Hedge Fund’s Favorite Equities

    By Meena Krishnamsetty - April 25, 2013 | Tickers: GM, NXY, SNY, TWTC, WAG

    Managed by the former head of Global Trading Strategies for Lehman Brothers, Realm Partners was started in 2009 by Robert Millard with $650 million. Before leaving Lehman as managing director in 2007, a year before Lehman filed for bankruptcy, Millard was given the highest pay package at the firm with $51.3 million, versus the $40 million paid to CEO Dick Fuld. Unfortunately, more than half of that was awarded more »

  • Missed the Rally? 4 Stocks Worth Buying at All-Time Highs

    By John Macris - April 23, 2013 | Tickers: ABC, KMX, VFC, WAG

    After nearly four months of strength, U.S. stocks showed their first chink in the armor as all three major indices dropped more than 2% during the week of April 15 -- the largest losses so far in the New Year.

    A pullback was seemingly inevitable as a growing number of market pundits cited poor economic data, persistent unemployment, and weakness in the commodity markets. All of these signs are legitimate more »

  • Is Walgreen a Good Stock to Buy?

    By Meena Krishnamsetty - April 20, 2013 | Tickers: CVS, ESRX, RAD, WMT, WAG

    In the last year, the stock price of Walgreen Company (NYSE: WAG) has risen 48% following the settlement of its dispute with Express Scripts (NASDAQ: ESRX). The second quarter of the $46 billion market cap retail pharmacy’s fiscal year ended in February, with Walgreen reporting flat revenue compared to the same period in the previous fiscal year. With lower cost of goods sold offsetting increases in SGA expenses, however more »

  • Finding A Balance Between Yield and Growth

    By Timothy Green - April 18, 2013 | Tickers: GE, INTC, WAG

    In the world of ultra-low interest rates in which we find ourselves today, many investors are drawn to dividend stocks that offer above-average yields. But dividend yields are only half the story, and the future rate of dividend growth is equally important. If the goal is to build a stream of dividend income then a balance needs to be found between yield and growth that gives investors the best results more »

  • 3 Drugstore Stocks You Must Own

    By Shweta Dubey - April 18, 2013 | Tickers: CVS, ESRX, WAG

    The drugstore industry is mainly driven by the growing demand for affordable medical treatment at feasible locations. 'Affordability' and 'accessibility' are the two key factors in a patient’s mind while undergoing any medical treatment. To meet the patient’s requirements, drugstores are expanding in order to provide customers with drugs and services at convenient locations.

    Additionally, the aging population and the improved usage of prescription medicines are acting as more »

  • Page 1 of 11